Global Human Papillomavirus (HPV) Testing Market Research Report 2022
SKU ID : QYR-21348530 | Publishing Date : 18-Jul-2022 | No. of pages : 113
Detailed TOC of Global Human Papillomavirus (HPV) Testing Market Research Report 2022
1 Report Overview1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Human Papillomavirus (HPV) Testing Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Pap Smear Test
1.2.3 HPV DNA Test
1.3 Market by Application
1.3.1 Global Human Papillomavirus (HPV) Testing Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Diagnostic Centers
1.3.3 Hospitals
1.3.4 Clinic
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Human Papillomavirus (HPV) Testing Market Perspective (2017-2028)
2.2 Human Papillomavirus (HPV) Testing Growth Trends by Region
2.2.1 Human Papillomavirus (HPV) Testing Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Human Papillomavirus (HPV) Testing Historic Market Size by Region (2017-2022)
2.2.3 Human Papillomavirus (HPV) Testing Forecasted Market Size by Region (2023-2028)
2.3 Human Papillomavirus (HPV) Testing Market Dynamics
2.3.1 Human Papillomavirus (HPV) Testing Industry Trends
2.3.2 Human Papillomavirus (HPV) Testing Market Drivers
2.3.3 Human Papillomavirus (HPV) Testing Market Challenges
2.3.4 Human Papillomavirus (HPV) Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Human Papillomavirus (HPV) Testing Players by Revenue
3.1.1 Global Top Human Papillomavirus (HPV) Testing Players by Revenue (2017-2022)
3.1.2 Global Human Papillomavirus (HPV) Testing Revenue Market Share by Players (2017-2022)
3.2 Global Human Papillomavirus (HPV) Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Human Papillomavirus (HPV) Testing Revenue
3.4 Global Human Papillomavirus (HPV) Testing Market Concentration Ratio
3.4.1 Global Human Papillomavirus (HPV) Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Human Papillomavirus (HPV) Testing Revenue in 2021
3.5 Human Papillomavirus (HPV) Testing Key Players Head office and Area Served
3.6 Key Players Human Papillomavirus (HPV) Testing Product Solution and Service
3.7 Date of Enter into Human Papillomavirus (HPV) Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Human Papillomavirus (HPV) Testing Breakdown Data by Type
4.1 Global Human Papillomavirus (HPV) Testing Historic Market Size by Type (2017-2022)
4.2 Global Human Papillomavirus (HPV) Testing Forecasted Market Size by Type (2023-2028)
5 Human Papillomavirus (HPV) Testing Breakdown Data by Application
5.1 Global Human Papillomavirus (HPV) Testing Historic Market Size by Application (2017-2022)
5.2 Global Human Papillomavirus (HPV) Testing Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Human Papillomavirus (HPV) Testing Market Size (2017-2028)
6.2 North America Human Papillomavirus (HPV) Testing Market Size by Country (2017-2022)
6.3 North America Human Papillomavirus (HPV) Testing Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Human Papillomavirus (HPV) Testing Market Size (2017-2028)
7.2 Europe Human Papillomavirus (HPV) Testing Market Size by Country (2017-2022)
7.3 Europe Human Papillomavirus (HPV) Testing Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Human Papillomavirus (HPV) Testing Market Size (2017-2028)
8.2 Asia-Pacific Human Papillomavirus (HPV) Testing Market Size by Country (2017-2022)
8.3 Asia-Pacific Human Papillomavirus (HPV) Testing Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Human Papillomavirus (HPV) Testing Market Size (2017-2028)
9.2 Latin America Human Papillomavirus (HPV) Testing Market Size by Country (2017-2022)
9.3 Latin America Human Papillomavirus (HPV) Testing Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Human Papillomavirus (HPV) Testing Market Size (2017-2028)
10.2 Middle East & Africa Human Papillomavirus (HPV) Testing Market Size by Country (2017-2022)
10.3 Middle East & Africa Human Papillomavirus (HPV) Testing Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Roche
11.1.1 Roche Company Detail
11.1.2 Roche Business Overview
11.1.3 Roche Human Papillomavirus (HPV) Testing Introduction
11.1.4 Roche Revenue in Human Papillomavirus (HPV) Testing Business (2017-2022)
11.1.5 Roche Recent Development
11.2 Agilent Technologies
11.2.1 Agilent Technologies Company Detail
11.2.2 Agilent Technologies Business Overview
11.2.3 Agilent Technologies Human Papillomavirus (HPV) Testing Introduction
11.2.4 Agilent Technologies Revenue in Human Papillomavirus (HPV) Testing Business (2017-2022)
11.2.5 Agilent Technologies Recent Development
11.3 Becton, DickinsonandCompany
11.3.1 Becton, DickinsonandCompany Company Detail
11.3.2 Becton, DickinsonandCompany Business Overview
11.3.3 Becton, DickinsonandCompany Human Papillomavirus (HPV) Testing Introduction
11.3.4 Becton, DickinsonandCompany Revenue in Human Papillomavirus (HPV) Testing Business (2017-2022)
11.3.5 Becton, DickinsonandCompany Recent Development
11.4 QiagenN.V.
11.4.1 QiagenN.V. Company Detail
11.4.2 QiagenN.V. Business Overview
11.4.3 QiagenN.V. Human Papillomavirus (HPV) Testing Introduction
11.4.4 QiagenN.V. Revenue in Human Papillomavirus (HPV) Testing Business (2017-2022)
11.4.5 QiagenN.V. Recent Development
11.5 Thermo FisherScientificInc.
11.5.1 Thermo FisherScientificInc. Company Detail
11.5.2 Thermo FisherScientificInc. Business Overview
11.5.3 Thermo FisherScientificInc. Human Papillomavirus (HPV) Testing Introduction
11.5.4 Thermo FisherScientificInc. Revenue in Human Papillomavirus (HPV) Testing Business (2017-2022)
11.5.5 Thermo FisherScientificInc. Recent Development
11.6 Abbott Laboratories
11.6.1 Abbott Laboratories Company Detail
11.6.2 Abbott Laboratories Business Overview
11.6.3 Abbott Laboratories Human Papillomavirus (HPV) Testing Introduction
11.6.4 Abbott Laboratories Revenue in Human Papillomavirus (HPV) Testing Business (2017-2022)
11.6.5 Abbott Laboratories Recent Development
11.7 HologicInc.
11.7.1 HologicInc. Company Detail
11.7.2 HologicInc. Business Overview
11.7.3 HologicInc. Human Papillomavirus (HPV) Testing Introduction
11.7.4 HologicInc. Revenue in Human Papillomavirus (HPV) Testing Business (2017-2022)
11.7.5 HologicInc. Recent Development
11.8 CepheidInc.
11.8.1 CepheidInc. Company Detail
11.8.2 CepheidInc. Business Overview
11.8.3 CepheidInc. Human Papillomavirus (HPV) Testing Introduction
11.8.4 CepheidInc. Revenue in Human Papillomavirus (HPV) Testing Business (2017-2022)
11.8.5 CepheidInc. Recent Development
11.9 SeegeneInc.
11.9.1 SeegeneInc. Company Detail
11.9.2 SeegeneInc. Business Overview
11.9.3 SeegeneInc. Human Papillomavirus (HPV) Testing Introduction
11.9.4 SeegeneInc. Revenue in Human Papillomavirus (HPV) Testing Business (2017-2022)
11.9.5 SeegeneInc. Recent Development
11.10 TakaraBio Inc.
11.10.1 TakaraBio Inc. Company Detail
11.10.2 TakaraBio Inc. Business Overview
11.10.3 TakaraBio Inc. Human Papillomavirus (HPV) Testing Introduction
11.10.4 TakaraBio Inc. Revenue in Human Papillomavirus (HPV) Testing Business (2017-2022)
11.10.5 TakaraBio Inc. Recent Development
11.11 DaAnGeneof SunYat-SenUniversity
11.11.1 DaAnGeneof SunYat-SenUniversity Company Detail
11.11.2 DaAnGeneof SunYat-SenUniversity Business Overview
11.11.3 DaAnGeneof SunYat-SenUniversity Human Papillomavirus (HPV) Testing Introduction
11.11.4 DaAnGeneof SunYat-SenUniversity Revenue in Human Papillomavirus (HPV) Testing Business (2017-2022)
11.11.5 DaAnGeneof SunYat-SenUniversity Recent Development
11.12 PromegaCorporation
11.12.1 PromegaCorporation Company Detail
11.12.2 PromegaCorporation Business Overview
11.12.3 PromegaCorporation Human Papillomavirus (HPV) Testing Introduction
11.12.4 PromegaCorporation Revenue in Human Papillomavirus (HPV) Testing Business (2017-2022)
11.12.5 PromegaCorporation Recent Development
11.13 GreinerBio-OneInternationalGmbH(GreinerHoldingAG)
11.13.1 GreinerBio-OneInternationalGmbH(GreinerHoldingAG) Company Detail
11.13.2 GreinerBio-OneInternationalGmbH(GreinerHoldingAG) Business Overview
11.13.3 GreinerBio-OneInternationalGmbH(GreinerHoldingAG) Human Papillomavirus (HPV) Testing Introduction
11.13.4 GreinerBio-OneInternationalGmbH(GreinerHoldingAG) Revenue in Human Papillomavirus (HPV) Testing Business (2017-2022)
11.13.5 GreinerBio-OneInternationalGmbH(GreinerHoldingAG) Recent Development
11.14 Enzo Biochem Inc.
11.14.1 Enzo Biochem Inc. Company Detail
11.14.2 Enzo Biochem Inc. Business Overview
11.14.3 Enzo Biochem Inc. Human Papillomavirus (HPV) Testing Introduction
11.14.4 Enzo Biochem Inc. Revenue in Human Papillomavirus (HPV) Testing Business (2017-2022)
11.14.5 Enzo Biochem Inc. Recent Development
11.15 NorgenBiotek
11.15.1 NorgenBiotek Company Detail
11.15.2 NorgenBiotek Business Overview
11.15.3 NorgenBiotek Human Papillomavirus (HPV) Testing Introduction
11.15.4 NorgenBiotek Revenue in Human Papillomavirus (HPV) Testing Business (2017-2022)
11.15.5 NorgenBiotek Recent Development
11.16 DiagCorBioscienceIncLtd
11.16.1 DiagCorBioscienceIncLtd Company Detail
11.16.2 DiagCorBioscienceIncLtd Business Overview
11.16.3 DiagCorBioscienceIncLtd Human Papillomavirus (HPV) Testing Introduction
11.16.4 DiagCorBioscienceIncLtd Revenue in Human Papillomavirus (HPV) Testing Business (2017-2022)
11.16.5 DiagCorBioscienceIncLtd Recent Development
11.17 Hybribio Limited
11.17.1 Hybribio Limited Company Detail
11.17.2 Hybribio Limited Business Overview
11.17.3 Hybribio Limited Human Papillomavirus (HPV) Testing Introduction
11.17.4 Hybribio Limited Revenue in Human Papillomavirus (HPV) Testing Business (2017-2022)
11.17.5 Hybribio Limited Recent Development
11.18 ZytovisionGmbH
11.18.1 ZytovisionGmbH Company Detail
11.18.2 ZytovisionGmbH Business Overview
11.18.3 ZytovisionGmbH Human Papillomavirus (HPV) Testing Introduction
11.18.4 ZytovisionGmbH Revenue in Human Papillomavirus (HPV) Testing Business (2017-2022)
11.18.5 ZytovisionGmbH Recent Development
11.19 ArborVitaCorporation
11.19.1 ArborVitaCorporation Company Detail
11.19.2 ArborVitaCorporation Business Overview
11.19.3 ArborVitaCorporation Human Papillomavirus (HPV) Testing Introduction
11.19.4 ArborVitaCorporation Revenue in Human Papillomavirus (HPV) Testing Business (2017-2022)
11.19.5 ArborVitaCorporation Recent Development
11.20 Medical& BiologicalLaboratoriesCo., Ltd
11.20.1 Medical& BiologicalLaboratoriesCo., Ltd Company Detail
11.20.2 Medical& BiologicalLaboratoriesCo., Ltd Business Overview
11.20.3 Medical& BiologicalLaboratoriesCo., Ltd Human Papillomavirus (HPV) Testing Introduction
11.20.4 Medical& BiologicalLaboratoriesCo., Ltd Revenue in Human Papillomavirus (HPV) Testing Business (2017-2022)
11.20.5 Medical& BiologicalLaboratoriesCo., Ltd Recent Development
11.21 Fujirebio Diagnostics
11.21.1 Fujirebio Diagnostics Company Detail
11.21.2 Fujirebio Diagnostics Business Overview
11.21.3 Fujirebio Diagnostics Human Papillomavirus (HPV) Testing Introduction
11.21.4 Fujirebio Diagnostics Revenue in Human Papillomavirus (HPV) Testing Business (2017-2022)
11.21.5 Fujirebio Diagnostics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Figures, Tables and Charts Available in Global Human Papillomavirus (HPV) Testing Market Research Report 2022
List of TablesTable 1. Global Human Papillomavirus (HPV) Testing Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Key Players of Pap Smear Test
Table 3. Key Players of HPV DNA Test
Table 4. Global Human Papillomavirus (HPV) Testing Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 5. Global Human Papillomavirus (HPV) Testing Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 6. Global Human Papillomavirus (HPV) Testing Market Size by Region (2017-2022) & (US$ Million)
Table 7. Global Human Papillomavirus (HPV) Testing Market Share by Region (2017-2022)
Table 8. Global Human Papillomavirus (HPV) Testing Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 9. Global Human Papillomavirus (HPV) Testing Market Share by Region (2023-2028)
Table 10. Human Papillomavirus (HPV) Testing Market Trends
Table 11. Human Papillomavirus (HPV) Testing Market Drivers
Table 12. Human Papillomavirus (HPV) Testing Market Challenges
Table 13. Human Papillomavirus (HPV) Testing Market Restraints
Table 14. Global Human Papillomavirus (HPV) Testing Revenue by Players (2017-2022) & (US$ Million)
Table 15. Global Human Papillomavirus (HPV) Testing Market Share by Players (2017-2022)
Table 16. Global Top Human Papillomavirus (HPV) Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Papillomavirus (HPV) Testing as of 2021)
Table 17. Ranking of Global Top Human Papillomavirus (HPV) Testing Companies by Revenue (US$ Million) in 2021
Table 18. Global 5 Largest Players Market Share by Human Papillomavirus (HPV) Testing Revenue (CR5 and HHI) & (2017-2022)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Human Papillomavirus (HPV) Testing Product Solution and Service
Table 21. Date of Enter into Human Papillomavirus (HPV) Testing Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Human Papillomavirus (HPV) Testing Market Size by Type (2017-2022) & (US$ Million)
Table 24. Global Human Papillomavirus (HPV) Testing Revenue Market Share by Type (2017-2022)
Table 25. Global Human Papillomavirus (HPV) Testing Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 26. Global Human Papillomavirus (HPV) Testing Revenue Market Share by Type (2023-2028)
Table 27. Global Human Papillomavirus (HPV) Testing Market Size by Application (2017-2022) & (US$ Million)
Table 28. Global Human Papillomavirus (HPV) Testing Revenue Market Share by Application (2017-2022)
Table 29. Global Human Papillomavirus (HPV) Testing Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 30. Global Human Papillomavirus (HPV) Testing Revenue Market Share by Application (2023-2028)
Table 31. North America Human Papillomavirus (HPV) Testing Market Size by Country (2017-2022) & (US$ Million)
Table 32. North America Human Papillomavirus (HPV) Testing Market Size by Country (2023-2028) & (US$ Million)
Table 33. Europe Human Papillomavirus (HPV) Testing Market Size by Country (2017-2022) & (US$ Million)
Table 34. Europe Human Papillomavirus (HPV) Testing Market Size by Country (2023-2028) & (US$ Million)
Table 35. Asia-Pacific Human Papillomavirus (HPV) Testing Market Size by Region (2017-2022) & (US$ Million)
Table 36. Asia-Pacific Human Papillomavirus (HPV) Testing Market Size by Region (2023-2028) & (US$ Million)
Table 37. Latin America Human Papillomavirus (HPV) Testing Market Size by Country (2017-2022) & (US$ Million)
Table 38. Latin America Human Papillomavirus (HPV) Testing Market Size by Country (2023-2028) & (US$ Million)
Table 39. Middle East & Africa Human Papillomavirus (HPV) Testing Market Size by Country (2017-2022) & (US$ Million)
Table 40. Middle East & Africa Human Papillomavirus (HPV) Testing Market Size by Country (2023-2028) & (US$ Million)
Table 41. Roche Company Detail
Table 42. Roche Business Overview
Table 43. Roche Human Papillomavirus (HPV) Testing Product
Table 44. Roche Revenue in Human Papillomavirus (HPV) Testing Business (2017-2022) & (US$ Million)
Table 45. Roche Recent Development
Table 46. Agilent Technologies Company Detail
Table 47. Agilent Technologies Business Overview
Table 48. Agilent Technologies Human Papillomavirus (HPV) Testing Product
Table 49. Agilent Technologies Revenue in Human Papillomavirus (HPV) Testing Business (2017-2022) & (US$ Million)
Table 50. Agilent Technologies Recent Development
Table 51. Becton, DickinsonandCompany Company Detail
Table 52. Becton, DickinsonandCompany Business Overview
Table 53. Becton, DickinsonandCompany Human Papillomavirus (HPV) Testing Product
Table 54. Becton, DickinsonandCompany Revenue in Human Papillomavirus (HPV) Testing Business (2017-2022) & (US$ Million)
Table 55. Becton, DickinsonandCompany Recent Development
Table 56. QiagenN.V. Company Detail
Table 57. QiagenN.V. Business Overview
Table 58. QiagenN.V. Human Papillomavirus (HPV) Testing Product
Table 59. QiagenN.V. Revenue in Human Papillomavirus (HPV) Testing Business (2017-2022) & (US$ Million)
Table 60. QiagenN.V. Recent Development
Table 61. Thermo FisherScientificInc. Company Detail
Table 62. Thermo FisherScientificInc. Business Overview
Table 63. Thermo FisherScientificInc. Human Papillomavirus (HPV) Testing Product
Table 64. Thermo FisherScientificInc. Revenue in Human Papillomavirus (HPV) Testing Business (2017-2022) & (US$ Million)
Table 65. Thermo FisherScientificInc. Recent Development
Table 66. Abbott Laboratories Company Detail
Table 67. Abbott Laboratories Business Overview
Table 68. Abbott Laboratories Human Papillomavirus (HPV) Testing Product
Table 69. Abbott Laboratories Revenue in Human Papillomavirus (HPV) Testing Business (2017-2022) & (US$ Million)
Table 70. Abbott Laboratories Recent Development
Table 71. HologicInc. Company Detail
Table 72. HologicInc. Business Overview
Table 73. HologicInc. Human Papillomavirus (HPV) Testing Product
Table 74. HologicInc. Revenue in Human Papillomavirus (HPV) Testing Business (2017-2022) & (US$ Million)
Table 75. HologicInc. Recent Development
Table 76. CepheidInc. Company Detail
Table 77. CepheidInc. Business Overview
Table 78. CepheidInc. Human Papillomavirus (HPV) Testing Product
Table 79. CepheidInc. Revenue in Human Papillomavirus (HPV) Testing Business (2017-2022) & (US$ Million)
Table 80. CepheidInc. Recent Development
Table 81. SeegeneInc. Company Detail
Table 82. SeegeneInc. Business Overview
Table 83. SeegeneInc. Human Papillomavirus (HPV) Testing Product
Table 84. SeegeneInc. Revenue in Human Papillomavirus (HPV) Testing Business (2017-2022) & (US$ Million)
Table 85. SeegeneInc. Recent Development
Table 86. TakaraBio Inc. Company Detail
Table 87. TakaraBio Inc. Business Overview
Table 88. TakaraBio Inc. Human Papillomavirus (HPV) Testing Product
Table 89. TakaraBio Inc. Revenue in Human Papillomavirus (HPV) Testing Business (2017-2022) & (US$ Million)
Table 90. TakaraBio Inc. Recent Development
Table 91. DaAnGeneof SunYat-SenUniversity Company Detail
Table 92. DaAnGeneof SunYat-SenUniversity Business Overview
Table 93. DaAnGeneof SunYat-SenUniversity Human Papillomavirus (HPV) TestingProduct
Table 94. DaAnGeneof SunYat-SenUniversity Revenue in Human Papillomavirus (HPV) Testing Business (2017-2022) & (US$ Million)
Table 95. DaAnGeneof SunYat-SenUniversity Recent Development
Table 96. PromegaCorporation Company Detail
Table 97. PromegaCorporation Business Overview
Table 98. PromegaCorporation Human Papillomavirus (HPV) TestingProduct
Table 99. PromegaCorporation Revenue in Human Papillomavirus (HPV) Testing Business (2017-2022) & (US$ Million)
Table 100. PromegaCorporation Recent Development
Table 101. GreinerBio-OneInternationalGmbH(GreinerHoldingAG) Company Detail
Table 102. GreinerBio-OneInternationalGmbH(GreinerHoldingAG) Business Overview
Table 103. GreinerBio-OneInternationalGmbH(GreinerHoldingAG) Human Papillomavirus (HPV) TestingProduct
Table 104. GreinerBio-OneInternationalGmbH(GreinerHoldingAG) Revenue in Human Papillomavirus (HPV) Testing Business (2017-2022) & (US$ Million)
Table 105. GreinerBio-OneInternationalGmbH(GreinerHoldingAG) Recent Development
Table 106. Enzo Biochem Inc. Company Detail
Table 107. Enzo Biochem Inc. Business Overview
Table 108. Enzo Biochem Inc. Human Papillomavirus (HPV) TestingProduct
Table 109. Enzo Biochem Inc. Revenue in Human Papillomavirus (HPV) Testing Business (2017-2022) & (US$ Million)
Table 110. Enzo Biochem Inc. Recent Development
Table 111. NorgenBiotek Company Detail
Table 112. NorgenBiotek Business Overview
Table 113. NorgenBiotek Human Papillomavirus (HPV) TestingProduct
Table 114. NorgenBiotek Revenue in Human Papillomavirus (HPV) Testing Business (2017-2022) & (US$ Million)
Table 115. NorgenBiotek Recent Development
Table 116. DiagCorBioscienceIncLtd Company Detail
Table 117. DiagCorBioscienceIncLtd Business Overview
Table 118. DiagCorBioscienceIncLtd Human Papillomavirus (HPV) TestingProduct
Table 119. DiagCorBioscienceIncLtd Revenue in Human Papillomavirus (HPV) Testing Business (2017-2022) & (US$ Million)
Table 120. DiagCorBioscienceIncLtd Recent Development
Table 121. Hybribio Limited Company Detail
Table 122. Hybribio Limited Business Overview
Table 123. Hybribio Limited Human Papillomavirus (HPV) TestingProduct
Table 124. Hybribio Limited Revenue in Human Papillomavirus (HPV) Testing Business (2017-2022) & (US$ Million)
Table 125. Hybribio Limited Recent Development
Table 126. ZytovisionGmbH Company Detail
Table 127. ZytovisionGmbH Business Overview
Table 128. ZytovisionGmbH Human Papillomavirus (HPV) TestingProduct
Table 129. ZytovisionGmbH Revenue in Human Papillomavirus (HPV) Testing Business (2017-2022) & (US$ Million)
Table 130. ZytovisionGmbH Recent Development
Table 131. ArborVitaCorporation Company Detail
Table 132. ArborVitaCorporation Business Overview
Table 133. ArborVitaCorporation Human Papillomavirus (HPV) TestingProduct
Table 134. ArborVitaCorporation Revenue in Human Papillomavirus (HPV) Testing Business (2017-2022) & (US$ Million)
Table 135. ArborVitaCorporation Recent Development
Table 136. Medical& BiologicalLaboratoriesCo., Ltd Company Detail
Table 137. Medical& BiologicalLaboratoriesCo., Ltd Business Overview
Table 138. Medical& BiologicalLaboratoriesCo., Ltd Human Papillomavirus (HPV) TestingProduct
Table 139. Medical& BiologicalLaboratoriesCo., Ltd Revenue in Human Papillomavirus (HPV) Testing Business (2017-2022) & (US$ Million)
Table 140. Medical& BiologicalLaboratoriesCo., Ltd Recent Development
Table 141. Fujirebio Diagnostics Company Detail
Table 142. Fujirebio Diagnostics Business Overview
Table 143. Fujirebio Diagnostics Human Papillomavirus (HPV) TestingProduct
Table 144. Fujirebio Diagnostics Revenue in Human Papillomavirus (HPV) Testing Business (2017-2022) & (US$ Million)
Table 145. Fujirebio Diagnostics Recent Development
Table 146. Research Programs/Design for This Report
Table 147. Key Data Information from Secondary Sources
Table 148. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Human Papillomavirus (HPV) Testing Market Share by Type: 2021 VS 2028
Figure 2. Pap Smear Test Features
Figure 3. HPV DNA Test Features
Figure 4. Global Human Papillomavirus (HPV) Testing Market Share by Application in 2021 & 2028
Figure 5. Diagnostic Centers Case Studies
Figure 6. Hospitals Case Studies
Figure 7. Clinic Case Studies
Figure 8. Human Papillomavirus (HPV) Testing Report Years Considered
Figure 9. Global Human Papillomavirus (HPV) Testing Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 10. Global Human Papillomavirus (HPV) Testing Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 11. Global Human Papillomavirus (HPV) Testing Market Share by Region: 2021 VS 2028
Figure 12. Global Human Papillomavirus (HPV) Testing Market Share by Players in 2021
Figure 13. Global Top Human Papillomavirus (HPV) Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Papillomavirus (HPV) Testing as of 2021)
Figure 14. The Top 10 and 5 Players Market Share by Human Papillomavirus (HPV) Testing Revenue in 2021
Figure 15. North America Human Papillomavirus (HPV) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 16. North America Human Papillomavirus (HPV) Testing Market Share by Country (2017-2028)
Figure 17. United States Human Papillomavirus (HPV) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 18. Canada Human Papillomavirus (HPV) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 19. Europe Human Papillomavirus (HPV) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 20. Europe Human Papillomavirus (HPV) Testing Market Share by Country (2017-2028)
Figure 21. Germany Human Papillomavirus (HPV) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. France Human Papillomavirus (HPV) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. U.K. Human Papillomavirus (HPV) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. Italy Human Papillomavirus (HPV) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. Russia Human Papillomavirus (HPV) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. Nordic Countries Human Papillomavirus (HPV) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. Asia-Pacific Human Papillomavirus (HPV) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Asia-Pacific Human Papillomavirus (HPV) Testing Market Share by Region (2017-2028)
Figure 29. China Human Papillomavirus (HPV) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Japan Human Papillomavirus (HPV) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. South Korea Human Papillomavirus (HPV) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Southeast Asia Human Papillomavirus (HPV) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. India Human Papillomavirus (HPV) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Australia Human Papillomavirus (HPV) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. Latin America Human Papillomavirus (HPV) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. Latin America Human Papillomavirus (HPV) Testing Market Share by Country (2017-2028)
Figure 37. Mexico Human Papillomavirus (HPV) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Brazil Human Papillomavirus (HPV) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Middle East & Africa Human Papillomavirus (HPV) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Middle East & Africa Human Papillomavirus (HPV) Testing Market Share by Country (2017-2028)
Figure 41. Turkey Human Papillomavirus (HPV) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Saudi Arabia Human Papillomavirus (HPV) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. Roche Revenue Growth Rate in Human Papillomavirus (HPV) Testing Business (2017-2022)
Figure 44. Agilent Technologies Revenue Growth Rate in Human Papillomavirus (HPV) Testing Business (2017-2022)
Figure 45. Becton, DickinsonandCompany Revenue Growth Rate in Human Papillomavirus (HPV) Testing Business (2017-2022)
Figure 46. QiagenN.V. Revenue Growth Rate in Human Papillomavirus (HPV) Testing Business (2017-2022)
Figure 47. Thermo FisherScientificInc. Revenue Growth Rate in Human Papillomavirus (HPV) Testing Business (2017-2022)
Figure 48. Abbott Laboratories Revenue Growth Rate in Human Papillomavirus (HPV) Testing Business (2017-2022)
Figure 49. HologicInc. Revenue Growth Rate in Human Papillomavirus (HPV) Testing Business (2017-2022)
Figure 50. CepheidInc. Revenue Growth Rate in Human Papillomavirus (HPV) Testing Business (2017-2022)
Figure 51. SeegeneInc. Revenue Growth Rate in Human Papillomavirus (HPV) Testing Business (2017-2022)
Figure 52. TakaraBio Inc. Revenue Growth Rate in Human Papillomavirus (HPV) Testing Business (2017-2022)
Figure 53. DaAnGeneof SunYat-SenUniversity Revenue Growth Rate in Human Papillomavirus (HPV) Testing Business (2017-2022)
Figure 54. PromegaCorporation Revenue Growth Rate in Human Papillomavirus (HPV) Testing Business (2017-2022)
Figure 55. GreinerBio-OneInternationalGmbH(GreinerHoldingAG) Revenue Growth Rate in Human Papillomavirus (HPV) Testing Business (2017-2022)
Figure 56. Enzo Biochem Inc. Revenue Growth Rate in Human Papillomavirus (HPV) Testing Business (2017-2022)
Figure 57. NorgenBiotek Revenue Growth Rate in Human Papillomavirus (HPV) Testing Business (2017-2022)
Figure 58. DiagCorBioscienceIncLtd Revenue Growth Rate in Human Papillomavirus (HPV) Testing Business (2017-2022)
Figure 59. Hybribio Limited Revenue Growth Rate in Human Papillomavirus (HPV) Testing Business (2017-2022)
Figure 60. ZytovisionGmbH Revenue Growth Rate in Human Papillomavirus (HPV) Testing Business (2017-2022)
Figure 61. ArborVitaCorporation Revenue Growth Rate in Human Papillomavirus (HPV) Testing Business (2017-2022)
Figure 62. Medical& BiologicalLaboratoriesCo., Ltd Revenue Growth Rate in Human Papillomavirus (HPV) Testing Business (2017-2022)
Figure 63. Fujirebio Diagnostics Revenue Growth Rate in Human Papillomavirus (HPV) Testing Business (2017-2022)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
Keyplayers in Global Human Papillomavirus (HPV) Testing Market Research Report 2022
RocheAgilent Technologies
Becton, DickinsonandCompany
QiagenN.V.
Thermo FisherScientificInc.
Abbott Laboratories
HologicInc.
CepheidInc.
SeegeneInc.
TakaraBio Inc.
DaAnGeneof SunYat-SenUniversity
PromegaCorporation
GreinerBio-OneInternationalGmbH(GreinerHoldingAG)
Enzo Biochem Inc.
NorgenBiotek
DiagCorBioscienceIncLtd
Hybribio Limited
ZytovisionGmbH
ArborVitaCorporation
Medical& BiologicalLaboratoriesCo., Ltd
Fujirebio Diagnostics